Aliases & Classifications for Drug Psychosis

MalaCards integrated aliases for Drug Psychosis:

Name: Drug Psychosis 12 14
Drug-Induced Psychotic Disorder 12
Psychoses, Substance-Induced 42
Drug-Induced Psychosis 12
Psychoses, Drug 69

Classifications:



External Ids:

Disease Ontology 12 DOID:1742
ICD9CM 35 292.1
MeSH 42 D011605
UMLS 69 C0033937

Summaries for Drug Psychosis

MalaCards based summary : Drug Psychosis, also known as drug-induced psychotic disorder, is related to schizophrenia and paranoid personality disorder. An important gene associated with Drug Psychosis is HTR1A (5-Hydroxytryptamine Receptor 1A), and among its related pathways/superpathways are Serotonergic synapse and GPCRs, Other. The drugs Asenapine and Aripiprazole have been mentioned in the context of this disorder. Affiliated tissues include brain, testes and heart, and related phenotypes are shRNA abundance <= 50% and behavior/neurological

Related Diseases for Drug Psychosis

Diseases related to Drug Psychosis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 57)
id Related Disease Score Top Affiliating Genes
1 schizophrenia 28.1 CNR1 DRD2 HTR1A HTR2A HTR7
2 paranoid personality disorder 10.8 HTR1A HTR2A
3 polyneuropathy 10.8 HTR1A HTR2A
4 hodgkin's granuloma 10.8 HTR1A HTR2A
5 teebi kaurah syndrome 10.4 DRD2 HTR2A
6 splenic abscess 10.4 DRD2 HTR2A
7 hyperthyroxinemia 10.4 DRD2 HTR2A
8 kidney cortex necrosis 10.4 NDUFS4 PHB2
9 pompholyx 10.4 DRD2 HTR1A HTR2A
10 abnormal pupillary function 10.4 HTR1A HTR7
11 neuronal ceroid-lipofuscinoses 10.4 LHB PHB2
12 postencephalitic parkinson disease 10.4 DRD2 HTR1A HTR2A
13 cecal benign neoplasm 10.4 DRD2 HTR1A HTR2A
14 bladder flat intraepithelial lesion 10.4 DRD2 HTR1A HTR2A
15 optic disk drusen 10.4 IDH1 IDH2
16 nemaline myopathy 10.3 IDH1 IDH2
17 hepatitis d 10.3 DRD2 HTR1A HTR2A
18 endolymphatic sac tumor 10.3 IDH1 IDH2
19 mixed oligodendroglioma-astrocytoma 10.3 IDH1 IDH2
20 indeterminate leprosy 10.3 HTR2A HTR7
21 congenital disorder of glycosylation, type if 10.3 IDH1 IDH2
22 hepatic angiomyolipoma 10.3 CNR1 HTR2A PINK1
23 hereditary multiple exostoses 10.3 CNR1 DRD2 HTR2A
24 pauci-immune glomerulonephritis with anca 10.3 DRD2 HTR2A NDUFS4
25 aicardi-goutieres syndrome 2 10.3 DRD2 HTR1A HTR2A
26 anca-associated vasculitis 10.3 IDH1 IDH2
27 partial motor epilepsy 10.3 DRD2 HTR1A HTR2A
28 essential pentosuria 10.3 IDH1 IDH2
29 bone osteosarcoma 10.3 IDH1 IDH2
30 breast papillomatosis 10.3 IDH1 IDH2
31 acute pre-b-cell lymphoblastic leukemia 10.2 IDH1 IDH2
32 conjunctival degeneration 10.2 HTR1A HTR2A HTR7
33 early myoclonic encephalopathy 10.2 IDH1 IDH2
34 neurotic disorder 10.2 IDH1 IDH2
35 keratosis 10.2 HTR1A HTR2A HTR7
36 pyromania 10.2 DRD2 HTR2A
37 juxtacortical chondrosarcoma 10.1 IDH1 IDH2
38 chronic conjunctivitis 10.1 CNR1 DRD2 HTR1A HTR2A
39 neurogenic bladder 10.1 HTR2A HTR7
40 schwannoma of jugular foramen 9.9 IDH1 IDH2
41 anosognosia 9.9 DRD2 HTR1A
42 albinism, oculocutaneous, type v 9.8 DRD2 HTR1A HTR2A HTR7
43 autoimmune-related retinopathy and optic neuropathy 9.7 HTR1A HTR2A HTR7
44 capgras syndrome 9.7
45 koro 9.7
46 hyperimmunoglobulin syndrome 9.6 FOS HTR1A HTR7
47 breast epithelioid hemangioma 9.6 FOS IDH1
48 autoimmune disease of central nervous system 9.6 CNR1 FOS HTR7
49 semantic agnosia 9.6 CNR1 FOS HTR7
50 cervical adenosarcoma 9.6 CNR1 FOS HTR7

Graphical network of the top 20 diseases related to Drug Psychosis:



Diseases related to Drug Psychosis

Symptoms & Phenotypes for Drug Psychosis

GenomeRNAi Phenotypes related to Drug Psychosis according to GeneCards Suite gene sharing:

26
id Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 shRNA abundance <= 50% GR00343-S 9.36 ADAMTS2 DRD2 DUSP26 EPHA5 FOS HTR1A

MGI Mouse Phenotypes related to Drug Psychosis:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 9.97 CNR1 DRD2 FOS HTR1A HTR2A HTR7
2 growth/size/body region MP:0005378 9.96 PINK1 TCOF1 ADAMTS2 CNR1 DRD2 DUSP26
3 integument MP:0010771 9.7 ADAMTS2 CNR1 DRD2 FOS HTR7 NDUFS4
4 nervous system MP:0003631 9.61 CNR1 DRD2 EPHA5 FOS HTR1A HTR7
5 skeleton MP:0005390 9.28 ADAMTS2 CNR1 DRD2 FOS HTR2A IDH1

Drugs & Therapeutics for Drug Psychosis

Drugs for Drug Psychosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 1243)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Asenapine Approved Phase 4,Phase 3,Phase 2,Phase 1 85650-56-2, 65576-45-6 3001386
2
Aripiprazole Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 129722-12-9 60795
3
Carbamazepine Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 298-46-4 2554
4
Coal tar Approved Phase 4,Phase 2 8007-45-2
5
Dopamine Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 51-61-6, 62-31-7 681
6
Olanzapine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 132539-06-1 4585
7
Oxcarbazepine Approved Phase 4,Phase 2,Phase 3 28721-07-5 34312
8
Valproic Acid Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 99-66-1 3121
9
Ziprasidone Approved Phase 4,Phase 3,Phase 2,Phase 1 146939-27-7 60854
10
Ethanol Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 64-17-5 702
11
Lamotrigine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 84057-84-1 3878
12
Risperidone Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 106266-06-2 5073
13
Citalopram Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 59729-33-8 2771
14
Clozapine Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 5786-21-0 2818
15
Moxonidine Approved Phase 4 75438-57-2 4810
16
Alprazolam Approved, Illicit, Investigational Phase 4,Phase 3,Phase 2,Phase 1 28981-97-7 2118
17
Zolpidem Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 82626-48-0 5732
18 Zotepine Approved Phase 4 26615-21-4
19
Sulpiride Approved Phase 4,Phase 3,Phase 2,Phase 1 15676-16-1 5355
20
Guaifenesin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 93-14-1 3516
21
Methadone Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 76-99-3 4095
22
Varenicline Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 249296-44-4 5310966
23
Chlorpromazine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-53-3 2726
24
Haloperidol Approved Phase 4,Phase 3,Phase 2,Phase 1 52-86-8 3559
25
Methylphenidate Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 113-45-1 4158
26
Armodafinil Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 112111-43-0
27
Modafinil Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 68693-11-8 4236
28
Guanfacine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 29110-47-2 3519
29
Norepinephrine Approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 51-41-2 439260
30
Dexmedetomidine Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 76631-46-4, 113775-47-6 68602 5311068 56032
31
Propofol Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 2078-54-8 4943
32
Sevoflurane Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 28523-86-6 5206
33
Topiramate Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 97240-79-4 5284627
34
Bupropion Approved Phase 4,Phase 2,Phase 3,Phase 1 34841-39-9, 34911-55-2 444
35
Nicotine Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 54-11-5 942 89594
36
Histamine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 75614-87-8, 51-45-6 774
37
Mianserin Approved Phase 4,Phase 3,Phase 2,Early Phase 1 24219-97-4 4184
38
Mirtazapine Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 85650-52-8, 61337-67-5 4205
39
Amitriptyline Approved Phase 4,Phase 3,Phase 2,Phase 1 50-48-6 2160
40
Nortriptyline Approved Phase 4,Phase 3,Phase 1,Phase 2 72-69-5 4543
41
Paroxetine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 61869-08-7 43815
42
Perphenazine Approved Phase 4,Phase 3,Phase 2,Phase 1 58-39-9 4748
43
Sertraline Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 79617-96-2 68617
44
Trimipramine Approved Phase 4,Phase 3 739-71-9 5584 4055
45
Pregabalin Approved, Illicit, Investigational Phase 4,Phase 3,Phase 2,Early Phase 1 148553-50-8 5486971
46
Acetazolamide Approved, Vet_approved Phase 4 59-66-5 1986
47
Clobazam Approved, Illicit Phase 4,Phase 3 22316-47-8 2789
48
Clonazepam Approved, Illicit Phase 4,Phase 2,Phase 3 1622-61-3 2802
49
Ethosuximide Approved Phase 4 77-67-8 3291
50
Felbamate Approved Phase 4,Phase 2 25451-15-4 3331

Interventional clinical trials:

(show top 50) (show all 10000)

id Name Status NCT ID Phase Drugs
1 Quetiapine Extended Release (XR) for the Management of Psychotic Aggression or Agitation in Adult Acute Psychiatry Unknown status NCT00986167 Phase 4 Quetiapine XR
2 Investigator Initiated Study - Asenapine Early Psychosis Unknown status NCT01968161 Phase 4 Asenapine
3 A Study to Evaluate the Efficacy and Safety of Flexible Dose of Quetiapine Fumarate (Seroquel) Switching From Other Drugs in the Treatment of Acute Manic Patients With Bipolar Disorder Unknown status NCT00837343 Phase 4 quetiapine fumarate tablet (Seroquel)
4 Tolerance and Effect of Antipsychotics in Children and Adolescents With Psychosis Unknown status NCT01119014 Phase 4 Aripiprazole;Quetiapine
5 Agomelatine Treatment of Depression in Schizophrenia (AGOPSYCH) Unknown status NCT01822418 Phase 4 agomelatine
6 Comparative Efficacy and Acceptability of Antimanic Drugs in Acute Mania Unknown status NCT01893229 Phase 4 Lithium;Valproate;Oxcarbazepine;Quetiapine;Olanzapine;Ziprasidone
7 Improving Substance Use and Clinical Outcomes in Heavy Cannabis Users With Quetiapine Unknown status NCT01153490 Phase 4
8 Treatment of Alcohol Dependence and Comorbid Bipolar Disorder Unknown status NCT01015586 Phase 4 Lamotrigine;Placebo
9 Tandospirone Combined With Atypical Antipsychotic Drugs in Schizophrenia Unknown status NCT02040883 Phase 4 Risperidone/Olanzapine/Quetiapine/Ziprasidone/Aripiprazole;Tandospirone
10 Tolerability And Efficacy Of High Dose Escitalopram In The Treatment Of Patients Suffering From Schizophrenia And Obsessive-Compulsive Disorder (OCD) - An Open Label Study Unknown status NCT00708396 Phase 4 Escitalopram
11 Alleviating the Metabolic Side Effects of Antipsychotic Medications Unknown status NCT01567124 Phase 4 Moxonidine;Placebo;Moxonidine;Placebo
12 Efficacy of Omega-3 Fatty Acids on Borderline Personality Disorder Unknown status NCT00437099 Phase 4 Omacor®;Placebo
13 Drug Treatment Validation of Functional Magnetic Resonance Imaging in Generalized Anxiety Disorder Unknown status NCT00662259 Phase 4 Alprazolam (Xanax);Placebo
14 Heart Rate Changes in Schizophrenic and Bipolar Patients Under the Medication of Aripiprazole and Quetiapine Unknown status NCT01047215 Phase 4 Aripiprazole; Quetiapine
15 Reduction of Cardiovascular Risk in Severe Mental Illness Unknown status NCT01182012 Phase 4
16 Risperidone and Zotepine in the Treatment of Delirium Unknown status NCT00622011 Phase 4 Risperidone and Zolpidem for delirium
17 Association of Amisulpride Response in Schizophrenia With Brain Image Unknown status NCT02095938 Phase 4 amisulpride
18 Smoking Cessation Treatment for Methadone Maintenance Patients Unknown status NCT01027754 Phase 4 Varenicline;Placebo
19 Identifying Predictors of Response to Antipsychotics Using a Treatment Algorithm Unknown status NCT01016145 Phase 4 Antipsychotics;Antipsychotics
20 Methylphenidate vs. Risperidone for the Treatment of Children and Adolescents With ADHD and Disruptive Disorders Unknown status NCT02063945 Phase 4 Methylphenidate;Risperidone
21 Antipsychotic Effects on Brain Function in Schizophrenia Unknown status NCT01913327 Phase 4 Aripiprazole;Risperidone;Modafinil
22 PREvent First Episode Relapse (PREFER) Unknown status NCT00220714 Phase 4 atypical antipsychotics:oral vs. long-acting route
23 Guanfacine Adjunctive Treatment to Atypical Antipsychotics for Cognitive Dysfunction in Schizophrenia Unknown status NCT00469664 Phase 4 Guanfacine/Tenex
24 Cymbalta for Depression as a Complication of Bereavement Unknown status NCT00658931 Phase 4 Drug treatment with Cymbalta
25 Varenicline Adjunctive Treatment in Schizophrenia Unknown status NCT00492349 Phase 4 Varenicline;Placebo
26 Long Term Postoperative Cognitive Dysfunction in the Elderly Patients Unknown status NCT02301676 Phase 4 Sevoflurane;propofol
27 Topiramate in the Treatment of Pathological Gambling Unknown status NCT00245583 Phase 4 topiramate (Topomax)
28 Effects of 'Seroquel-XR' on the Improvement of Neurocognitive Function in People At-risk Mental States(ARMS) Unknown status NCT01250847 Phase 4 Quetiapine(Seroquel-XR) 50~800mg a day
29 Comparative Effectiveness of Post-Discharge Strategies for Hospitalized Smokers Unknown status NCT01714323 Phase 4
30 Hippocampal Volume in Young Patients With Major Depression Before and After Combined Antidepressive Therapy Unknown status NCT00150839 Phase 4 Mirtazapine;Venlafaxine
31 Optimizing Antidepressant Treatment by Genotype-dependent Adjustment of Medication According to the ABCB1 Gene Unknown status NCT02237937 Phase 4 Paroxetine;Sertraline;Citalopram;Venlafaxine;Amitriptyline;Escitalopram;Amitriptylinoxide;Nortriptyline;Trimipramine
32 Clinical Pharmacogenomics of Antidepressant Response Unknown status NCT00269334 Phase 4 Using Citalopram(drug) or Paroxetine(drug)
33 Pilot Study to Evaluate the Efficacy and Safety of Quetiapine Fumarate Instant-Release (Seroquel IR) in Controlling Agitation and Aggressive Symptoms in the Acute Treatment of Patients With Schizophrenia Unknown status NCT00838032 Phase 4 Quetiapine fumarate;Haloperidol
34 Medications for the Treatment of Dysthymic Disorder and Double Depression Unknown status NCT00234312 Phase 4 escitalopram and sertraline
35 Topiramate Augmentation in the Treatment of Obsessive-Compulsive Disorder Unknown status NCT00211744 Phase 4 topiramate
36 Perioperative Pregabalin Use, Rehabilitation, Pain Outcomes and Anxiety Following Hip Surgery Unknown status NCT00762099 Phase 4 Pregabalin;Placebo
37 The New Strategy for Pharmacological Treatment in People With Schizophrenia Unknown status NCT00352339 Phase 4 Rispridoen and Aripiprazole;Risperidne;Abilify
38 Divalproex Sodium ER in Adult Autism Unknown status NCT00211796 Phase 4 Divalproex Sodium ER
39 Prediction of Antidepressant Treatment Response Using Machine Learning Classification Analysis Unknown status NCT02330679 Phase 4 Desvenlafaxine;Placebo
40 Ketogenic Diet vs.Antiepileptic Drug Treatment in Drug Resistant Epilepsy Unknown status NCT00552526 Phase 4 Antiepileptic drug (AED)
41 A Double-blind, Placebo-controlled Trial of Donepezil Adjunctive Treatment for Cognitive Impairment in Schizophrenia Unknown status NCT01490567 Phase 4 Donepezil;placebo
42 Improving Outcomes in Psychosis Associated With Substance Use Using Aripiprazole Unknown status NCT01155544 Phase 4
43 Minocycline as an Adjunctive Therapy for Schizophrenia: a Randomized Controlled Study Unknown status NCT01133080 Phase 4 Minocycline;placebo
44 Remission of ICD by Switching Dopamine Agonist to Levodopa/Carbidopa Unknown status NCT01683253 Phase 4 Levodopa/Carbidopa(200mg/50mg)
45 Trial for the Treatment of Alcohol Dependence Unknown status NCT00120601 Phase 4 Naltrexone;Acamprosate
46 Optimization of Acute Treatment in First Episode Schizophrenia Unknown status NCT00157378 Phase 4 Risperidone, Haloperidol
47 Diabetes Prevention Program in Schizophrenia [DPPS] Unknown status NCT00182494 Phase 4
48 Predictors of Treatment Response to Fluoxetine in PTSD Following a Recent History of War Zone Stress Exposure Unknown status NCT00633685 Phase 4 Fluoxetine;Placebo
49 Comparison of Cognitive Functions of Schizophrenic Patients Treated With Sertindole Versus Risperidone Unknown status NCT00480844 Phase 4 Sertindole;Risperidone
50 Intuniv vs Placebo in the Treatment of Childhood Intermittent Explosive Disorder Unknown status NCT02048241 Phase 4 Intuniv

Search NIH Clinical Center for Drug Psychosis

Cochrane evidence based reviews: psychoses, substance-induced

Genetic Tests for Drug Psychosis

Anatomical Context for Drug Psychosis

MalaCards organs/tissues related to Drug Psychosis:

39
Brain, Testes, Heart, Bone, Breast, Prostate, Lung

Publications for Drug Psychosis

Articles related to Drug Psychosis:

id Title Authors Year
1
Analysis of overall gene expression induced by amphetamine and phencyclidine: novel targets for the treatment of drug psychosis and schizophrenia. ( 11812256 )
2002

Variations for Drug Psychosis

Expression for Drug Psychosis

Search GEO for disease gene expression data for Drug Psychosis.

Pathways for Drug Psychosis

GO Terms for Drug Psychosis

Cellular components related to Drug Psychosis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 axon GO:0030424 9.02 CNR1 DRD2 EPHA5 HTR2A PINK1

Biological processes related to Drug Psychosis according to GeneCards Suite gene sharing:

(show all 20)
id Name GO ID Score Top Affiliating Genes
1 G-protein coupled receptor signaling pathway GO:0007186 9.99 CNR1 DRD2 HTR1A HTR2A HTR7 LHB
2 mitochondrion organization GO:0007005 9.65 IDH2 PHB2 PINK1
3 response to light stimulus GO:0009416 9.59 DRD2 FOS
4 regulation of dopamine secretion GO:0014059 9.58 DRD2 HTR2A
5 behavioral response to cocaine GO:0048148 9.58 DRD2 HTR2A
6 temperature homeostasis GO:0001659 9.57 DRD2 HTR2A
7 smooth muscle contraction GO:0006939 9.56 HTR2A HTR7
8 2-oxoglutarate metabolic process GO:0006103 9.55 IDH1 IDH2
9 vasoconstriction GO:0042310 9.54 HTR1A HTR7
10 negative regulation of synaptic transmission, glutamatergic GO:0051967 9.52 DRD2 HTR2A
11 regulation of synaptic transmission, GABAergic GO:0032228 9.49 CNR1 DRD2
12 behavior GO:0007610 9.46 HTR1A HTR2A
13 sleep GO:0030431 9.43 FOS HTR2A
14 regulation of behavior GO:0050795 9.4 HTR1A HTR2A
15 regulation of hormone secretion GO:0046883 9.37 HTR1A HTR2A
16 isocitrate metabolic process GO:0006102 9.32 IDH1 IDH2
17 adenylate cyclase-inhibiting serotonin receptor signaling pathway GO:0007198 9.26 HTR1A HTR7
18 serotonin receptor signaling pathway GO:0007210 9.16 HTR1A HTR2A
19 negative regulation of dopamine secretion GO:0033602 8.96 CNR1 DRD2
20 glyoxylate cycle GO:0006097 8.62 IDH1 IDH2

Molecular functions related to Drug Psychosis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 signal transducer activity GO:0004871 9.71 CNR1 DRD2 HTR1A HTR2A
2 drug binding GO:0008144 9.54 CNR1 DRD2 HTR2A
3 neurotransmitter receptor activity GO:0030594 9.33 HTR1A HTR2A HTR7
4 isocitrate dehydrogenase (NADP+) activity GO:0004450 9.32 IDH1 IDH2
5 isocitrate dehydrogenase activity GO:0004448 9.26 IDH1 IDH2
6 G-protein coupled serotonin receptor activity GO:0004993 9.13 HTR1A HTR2A HTR7
7 serotonin binding GO:0051378 8.8 HTR1A HTR2A HTR7

Sources for Drug Psychosis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....